SLx-2101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SLx-2101, covering 2023-05-03 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension [Phase 2]